跳至主要内容
临床试验/NCT07070895
NCT07070895招募中不适用

A Prospective Decentralized Investigation of the Effect of a Cough Management Feature Inside a Wellness Application (CoughPro) in Refractory or Unexplained Chronic Cough (RCC/UCC)

Hyfe Inc1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Hyfe Inc
入组人数
20
试验地点
1
主要终点
Change in objective cough rate (coughs/hour)

研究概览

简要总结

The goal of this single-cohort clinical trial is to learn whether a smartphone-based Cough Management (CM) program can reduce cough frequency and burden in adults (21-80 years) who have refractory or unexplained chronic cough. 

The main questions it aims to answer are:

  • Does four weeks of using the CM feature in the CoughPro app lower objective cough rate (coughs per hour) compared with each participant's one-week baseline? 
  • Does the program also lessen cough intensity (bout metrics) and improve patient-reported quality-of-life scores on the Leicester Cough Questionnaire and PGI-S?

Participants will:

  • Wear a Hyfe CoughMonitor smartwatch continuously for 6 weeks (1-week baseline, 4-week intervention, 1-week follow-up), charging it nightly. 
  • Complete science-based in-app CM lessons based on behavioral cough-suppression therapy and practice the techniques during the 4-week intervention.
  • Fill out online questionnaires (LCQ and PGI-S) at baseline and at the end of Week 4.
  • Join a brief exit interview, then return the smartwatch and receive a compensation voucher.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 21 or older.
  • •Currently suffering from a cough that started at least 8 weeks ago that is largely unproductive (i.e., at least 50% of the time the cough produces zero mucus that needs to be spit out or swallowed).
  • •Normal chest X-ray or chest CT scan at some point that was prescribed specifically for their cough.
  • •At least one physician visit for cough with standard-of-care therapy but inadequate symptom relief.
  • •Stability of treatment: willing to avoid new cough treatments during study or report changes if they occur.
  • •Ability to comply: willing/able to wear the watch daily for the required duration of study and to complete all required questionnaires.
  • •Informed consent: understanding of the study procedures and agreement to comply with protocol.

排除标准

  • •Recent upper respiratory infection (past 4 weeks).
  • •History of hemoptysis (coughing up blood) since onset of the current cough.
  • •Current smoker (incl. vaping) of any substance.
  • •≥10 consecutive pack-years smoking history within <10 years prior to screening.
  • •Diagnosed with a chronic lung condition (COPD, emphysema, lung cancer, IPF, chronic bronchitis, asthma). Note: Suspected asthma without confirmed diagnosis or benefit from asthma therapy is not an exclusion.
  • •Current or past head/neck cancer.
  • •Difficulty swallowing.
  • •On ACE inhibitors, such as Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
  • •Prior treatment for cough by a speech-language pathologist.
  • •Living with another individual with a frequent cough that would interfere with monitoring.
  • •Participation in any cough intervention study within 30 days or 5 half-lives of the intervention.
  • •Major scheduled surgery during the study period.

研究组 & 干预措施

Cough Management

Experimental

CoughPro wellness application includes a Cough Management (CM) component, which delivers short, structured behavioral lessons (based on BCST) designed to help users recognize their urge to cough and apply cough suppression strategies in real-world settings. The Cough Management wellness feature is the key area of investigation in this study.

干预措施: Cough Management (Behavioral)

Cough Management

Experimental

CoughPro wellness application includes a Cough Management (CM) component, which delivers short, structured behavioral lessons (based on BCST) designed to help users recognize their urge to cough and apply cough suppression strategies in real-world settings. The Cough Management wellness feature is the key area of investigation in this study.

干预措施: CoughMonitor Suite (Device)

结局指标

主要结局

Change in objective cough rate (coughs/hour)

时间窗: From baseline (week minus 1) to end of Week 4

Change in objective cough rate (coughs/hours) from baseline (week minus 1) to end of Week 4, measured by the CoughMonitor smartwatch.

次要结局

  • Change in subjective impression of cough burden(From baseline to 4 weeks after starting the intervention.)
  • Change in cough intensity from baseline to end of Week 4(Fom baseline (week minus 1) to end of week 4)

研究者

发起方
Hyfe Inc
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验